Shenzhen Chipscreen Biosciences Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 335.67 million compared to CNY 276.55 million a year ago. Revenue was CNY 335.67 million compared to CNY 276.55 million a year ago.

Net loss was CNY 42.21 million compared to CNY 24.25 million a year ago. Basic loss per share from continuing operations was CNY 0.1037 compared to CNY 0.0591 a year ago. Diluted loss per share from continuing operations was CNY 0.1037 compared to CNY 0.0591 a year ago.